Zachary M. Sandusky

Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer

Katarzyna A. Ludwik, James Campbell, Mingzong Li et al. · Molecular Cancer Therapeutics · 2016 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17

Synthesis and Structure–Activity Relationship Study of 5a-Carbasugar Analogues of SL0101

Mingzong Li, Yu Li, Roman M. Mrozowski et al. · ACS Medicinal Chemistry Letters · 2014 · 34 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +13

Stereoselective Synthesis and Evaluation of C6″-Substituted 5a-Carbasugar Analogues of SL0101 as Inhibitors of RSK1/2

Mingzong Li, Yu Li, Katarzyna A. Ludwik et al. · Organic Letters · 2017 · 32 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

De Novo Synthesis and Biological Evaluation of C6″-Substituted C4″-Amide Analogues of SL0101

Roman M. Mrozowski, Zachary M. Sandusky, Rajender Vemula et al. · Organic Letters · 2014 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha

Katarzyna A. Ludwik, Zachary M. Sandusky, Kimberly M. Stauffer et al. · Cell Reports · 2020 · 15 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17